OncoC4 Announces NMPA Acceptance of Two IND Applications for Cesalatamig Combination Studies with ADCs and Pan-RAS Inhibitors ...Middle East

— New Studies Expand Cesalatamig into Biomarker-driven Precision Immuno-oncology Strategies — Cesalatamig is Also Being Evaluated in Ongoing Phase 2 Studies in the United States and in China ROCKVILLE, Md. , Oct. 19, 2026 /PRNewswire/ -- OncoC4 Inc., a late clinical-stage...

Hence then, the article about oncoc4 announces nmpa acceptance of two ind applications for cesalatamig combination studies with adcs and pan ras inhibitors was published today ( Monday 19/10/2026 - 02:17 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( OncoC4 Announces NMPA Acceptance of Two IND Applications for Cesalatamig Combination Studies with ADCs and Pan-RAS Inhibitors )

Also on site :

• Breakout Horror Film of the Year, ‘Obsession’, Hits Netflix Next Month
• Kylie Jenner Dazzles in $50 Million Victoria’s Secret Fantasy Bra in Jaw-Dropping Fashion Show Surprise
• Trinity Tatum Shares Her Love Island Villa Fashion Inspiration & What’s Next For Her .. Victoria Secret Fashion Show 2026